The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Cancer Immunotherapy: The Optogenetics Angle

    Article obtained from Optics and Photonics News RSS Feed.

    Ongoing research in “optoimmunoengineering” may help to extend the impact of Nobel Prize–winning work.

    Oct, 01 2018 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.